Enhanced mechanical properties of a novel unsintered hydroxyapatite/poly l-lactic acid (u-HA/PLLA) screw with a reverse buttress thread design
Journal of Orthopaedic Science · 2026-03 · 31 (2) · 450-455
DOI: 10.1016/j.jos.2025.08.013 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Orthopaedic Science, 2026-03. Verfasst von Takuya Wakatsuki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Shimane University Faculty of Medicine, 89-1 Enya, Izumo, Shimane 693-8501, Japan. Electronic address: waka87@med.…. Hauptthemen laut MEDLINE: Bone Screws, Polyesters, Durapatite. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Although bioabsorbable screws offer various advantages, they also have the clinical drawback of low inherent strength. We developed a novel u-HA/PLLA screw with an innovative shape that maintains the screw function while increasing its strength. The aim of this study was to assess the mechanical properties of this novel screw in comparison to the conventional type. METHODS: Both the novel and conventional screws had a major diameter of 4.5 mm and a pitch of 1.6 mm. The conventional type had a minor diameter of 3.5 mm (with thread depth of 0.5 mm) and utilized a buttress thread design. In contrast, the novel screw had a minor diameter of 3.7 mm (with thread depth of 0.4 mm) and a reverse buttress thread. Three-point bending, shear, and torsion tests were performed to compare the screw strengths (n = 10). In addition, to compare their pullout strengths, the screws were inserted into two types of simulated bone, one mimicking osteoporotic bone and the other healthy bone (n = 10 replicates for each condition). RESULTS: The novel screw exhibited 33 % higher three-point bending strength (p < 0.001), 23 % higher shear strength (p < 0.001), and 24 % higher torsion strength (p < 0.001) than the conventional screw. The fourth parameter of mechanical strength, pullout strength, was not significantly different between the screw types, regardless of the bone conditions. CONCLUSION: The novel u-HA/PLLA screw demonstrated superior mechanical strength while maintaining comparable pullout strength versus the conventional type.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Shimane University Faculty of Medicine, 89-1 Enya, Izumo, Shimane 693-8501, Japan. Electronic address: waka87@med.shimane-u.ac.jp.
- Department of Orthopaedic Surgery, Shimane University Faculty of Medicine, 89-1 Enya, Izumo, Shimane 693-8501, Japan.
- Department of Manufacturing Technology, Shimane Institute for Industrial Technology, 1 Hokuryo, Matsue, Shimane 690-0816, Japan.
- Teijin Medical Technologies Co., Ltd., 2-3-33 Nakanoshima, Kitaku, Osaka, Osaka 530-0005, Japan.
Zitieren
APA
Wakatsuki, T., Imade, S., Furuya, S., Morii, H., Oka, D., Nakazawa, K., Shiraishi, K., Manako, T., Sato, M., & Uchio, Y. (2026). Enhanced mechanical properties of a novel unsintered hydroxyapatite/poly l-lactic acid (u-HA/PLLA) screw with a reverse buttress thread design. Journal of Orthopaedic Science, 31(2), 450-455. https://doi.org/10.1016/j.jos.2025.08.013
Vancouver
Wakatsuki T, Imade S, Furuya S, Morii H, Oka D, Nakazawa K, et al. Enhanced mechanical properties of a novel unsintered hydroxyapatite/poly l-lactic acid (u-HA/PLLA) screw with a reverse buttress thread design. Journal of Orthopaedic Science. 2026;31(2):450-455. doi:10.1016/j.jos.2025.08.013
BibTeX
@article{Wakatsuki2026,
author = {Wakatsuki, Takuya and Imade, Shinji and Furuya, Satoshi and Morii, Hiroshi and Oka, Daishiro and Nakazawa, Koichiro and Shiraishi, Kazuma and Manako, Takuya and Sato, Masaya and Uchio, Yuji},
title = {Enhanced mechanical properties of a novel unsintered hydroxyapatite/poly l-lactic acid (u-HA/PLLA) screw with a reverse buttress thread design},
journal = {Journal of Orthopaedic Science},
year = {2026},
volume = {31},
number = {2},
pages = {450--455},
doi = {10.1016/j.jos.2025.08.013}
}
EUVIMED